| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
HLA-A |
IPI00719058 |
0.535 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
PTPNS1 |
SIRPA, BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP: Tyrosine-protein phosphatase non-rec |
0.535 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
0.535 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
0.535 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CRK |
CRK: Proto-oncogene C-crk |
0.535 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
EPHA3 |
EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor |
0.535 |
Evidence |
|
| SCT |
SCT: Secretin precursor |
GPR126 |
DREG: Developmentally regulated G-protein-coupled receptor alpha 1 |
0.535 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
O
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
0.535 |
Evidence |
|
| MMP7 |
MMP7, MPSL1, PUMP1: Matrilysin precursor |
AGC1 |
AGC1, CSPG1, MSK16: Aggrecan core protein precursor |
0.535 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
MST1 |
MST1, D3F15S2, DNF15S2, HGFL: Hepatocyte growth factor-like protein precursor |
0.535 |
Evidence |
|
| HCK |
IPI00029769 |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| HCK |
IPI00029769 |
NTRK2 |
NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor |
0.535 |
Evidence |
|
| HCK |
IPI00029769 |
PTK7 |
PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor |
0.535 |
Evidence |
|
| HCK |
IPI00029769 |
PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
0.535 |
Evidence |
|
| HCK |
IPI00029769 |
CRK |
CRK: Proto-oncogene C-crk |
0.535 |
Evidence |
|
| HCK |
IPI00029769 |
EPHA3 |
EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor |
0.535 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
SHC1 |
SHC1, SHC, SHCA: SHC-transforming protein 1 |
0.535 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.535 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
0.535 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
CRK |
CRK: Proto-oncogene C-crk |
0.535 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
0.535 |
Evidence |
|
| COL4A2 |
COL4A2: Collagen alpha-2(IV) chain precursor [Contains: Canstatin] |
SAA4 |
SAA4, CSAA: Serum amyloid A-4 protein precursor |
0.535 |
Evidence |
|